Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥2.27T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.16T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.89T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥956.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥118.4bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥50.3bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥153.1bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥66.1bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥122.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥46.9bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥147.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥61.9bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥73.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥29.1bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥85.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥91.5bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥38.2bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥101.9bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥42.7bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥6.00Tat 2022-09-30Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.32Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥2.04Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.67Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.63Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.32Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥253.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥257.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥93.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥166.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥117.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥107.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥15.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥151.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.022022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥20.442022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥59.942021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥24.82021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥49.792022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.582022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥55.132021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.822021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio27.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.8%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥205.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥108.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥96.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥6.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥6.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-09-30¥771.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥745.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥26.0bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥22.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥212.3bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥212.0bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥309m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-09-30¥573.7bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-09-30¥569.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-09-30¥54.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥659.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥634.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥42.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥2.22T
—segment totalrevenue external2022-04-01 → 2022-09-30¥2.16T
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥56.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥122.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥2.42T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥2.27T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥152.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥129.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥172.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥81.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥90.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥7.3bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-09-30¥614.8bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-09-30¥593.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥20.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-09-30¥62.2bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥198.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥198.5bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥171m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-09-30¥447.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-09-30¥444.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-09-30¥48.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥592.2bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥566.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥45.8bn
—segment totalrevenue2021-04-01 → 2021-09-30¥1.85T
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.80T
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥49.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥157.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.03T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.89T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥140.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥163.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 950
ItemContextValueUnit
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-2166000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-3888000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration-6054000000JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember389000000JPY
Business combinations or business divestitures ss IFRSCurrentYTDDuration389000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2688000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember2806000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember118000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration-JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2688000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember2806000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember118000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-23223000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-15707000000JPY
Total transactions with owners IFRSCurrentYTDDuration-38930000000JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember62666000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember138797000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember5768000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember207231000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1629241000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember414169000000JPY
Equity IFRSCurrentQuarterInstant2043410000000JPY
Profit loss before tax IFRSPrior1YTDDuration147165000000JPY
Profit loss before tax IFRSCurrentYTDDuration121967000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration124741000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration133841000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-9643000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-7207000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSPrior1YTDDuration4267000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSCurrentYTDDuration3816000000JPY
Gain on reversal of environmental expenses ope cf IFRSPrior1YTDDuration-JPY
Gain on reversal of environmental expenses ope cf IFRSCurrentYTDDuration-2389000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration3622000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration2327000000JPY
Loss gain on sale of fixed assets ope cf IFRSPrior1YTDDuration-1894000000JPY
Loss gain on sale of fixed assets ope cf IFRSCurrentYTDDuration-1149000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass